These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25362533)

  • 1. On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis.
    Grammenos D; Barker SA
    J Neural Transm (Vienna); 2015 Jun; 122(6):733-9. PubMed ID: 25362533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor.
    Su TP; Hayashi T; Vaupel DB
    Sci Signal; 2009 Mar; 2(61):pe12. PubMed ID: 19278957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N,N-Dimethyltryptamine-Induced Psychosis.
    Paterson NE; Darby WC; Sandhu PS
    Clin Neuropharmacol; 2015; 38(4):141-3. PubMed ID: 26166234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.
    Heekeren K; Neukirch A; Daumann J; Stoll M; Obradovic M; Kovar KA; Geyer MA; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2007 May; 21(3):312-20. PubMed ID: 17591658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users.
    Cakic V; Potkonyak J; Marshall A
    Drug Alcohol Depend; 2010 Sep; 111(1-2):30-7. PubMed ID: 20570058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine.
    Jacob MS; Presti DE
    Med Hypotheses; 2005; 64(5):930-7. PubMed ID: 15780487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ayahoasca: an experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia.
    Pomilio AB; Vitale AA; Ciprian-Ollivier J; Cetkovich-Bakmas M; Gómez R; Vázquez G
    J Ethnopharmacol; 1999 Apr; 65(1):29-51. PubMed ID: 10350367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).
    Cameron LP; Olson DE
    ACS Chem Neurosci; 2018 Oct; 9(10):2344-2357. PubMed ID: 30036036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Physician's Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT).
    Brown T; Shao W; Ayub S; Chong D; Cornelius C
    J Psychoactive Drugs; 2017; 49(4):294-296. PubMed ID: 28686543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator.
    Fontanilla D; Johannessen M; Hajipour AR; Cozzi NV; Jackson MB; Ruoho AE
    Science; 2009 Feb; 323(5916):934-7. PubMed ID: 19213917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Daumann J; Obradovic M; Kovar KA
    Neuropsychopharmacology; 2006 Feb; 31(2):431-41. PubMed ID: 16123739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of N,N-dimethyltryptamine (DMT) on tests of psychoticism (author's transl)].
    Bickel P; Dittrich A; Schöpf J
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Jan; 10(1):10-4. PubMed ID: 329291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Dimethyltryptamine and psychosis.
    Lancet; 1974 Jul; 2(7873):140-1. PubMed ID: 4135558
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased excretion of dimethyltryptamine and certain features of psychosis: a possible association.
    Murray RM; Oon MC; Rodnight R; Birley JL; Smith A
    Arch Gen Psychiatry; 1979 Jun; 36(6):644-9. PubMed ID: 286576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic, Intermittent Microdoses of the Psychedelic
    Cameron LP; Benson CJ; DeFelice BC; Fiehn O; Olson DE
    ACS Chem Neurosci; 2019 Jul; 10(7):3261-3270. PubMed ID: 30829033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study.
    Riba J; McIlhenny EH; Bouso JC; Barker SA
    Drug Test Anal; 2015 May; 7(5):401-6. PubMed ID: 25069786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine.
    Gillin JC; Kaplan J; Stillman R; Wyatt RJ
    Am J Psychiatry; 1976 Feb; 133(2):203-8. PubMed ID: 1062171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
    Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
    Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the brain levels of N,N-dimethyltryptamine and alpha, alpha, beta, beta-tetradeutero-N-N-dimethyltryptamine following intraperitoneal injection. The in vivo kinetic isotope effect.
    Barker SA; Beaton JM; Christian ST; Monti JA; Morris PE
    Biochem Pharmacol; 1982 Aug; 31(15):2513-6. PubMed ID: 6812592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.